Evidence map›Paper›PMID 26692710›Full record

ArticleMiddle East African journal of ophthalmology

Myths in the Diagnosis and Management of Orbital Tumors.

Kaan Gündüz, Özge Yanık

Abstract readCase Reports
In one paragraph

Article in Middle East African journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. [Alternative treatment options for periorbital basal cell carcinoma].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kaan GündüzDepartment of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey.
Özge YanıkDepartment of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey.
Ankara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orbital tumors constitute a group of diverse lesions with a low incidence in the population. Tumors affecting the eye and ocular adnexa may also secondarily invade the orbit. Lack of accumulation of a sufficient number of cases with a specific diagnosis at various orbital centers, the paucity of prospective randomized studies, animal model studies, tissue bank, and genetic studies led to the development of various myths regarding the diagnosis and treatment of orbital lesions in the past. These myths continue to influence the diagnosis and treatment of orbital lesions by orbital specialists. This manuscript discusses some of the more common myths through case summaries and a review of the literature. Detailed genotypic analysis and genetic classification will provide further insight into the pathogenesis of many orbital diseases in the future. This will enable targeted treatments even for diseases with the same histopathologic diagnosis. Phenotypic variability within the same disease will be addressed using targeted treatments.

Indexed as

AdultAgedBiopsyCarcinoma, Squamous CellEyelid NeoplasmsFemaleHemangioma, CavernousHumansMagnetic Resonance ImagingMaleNeoplasm InvasivenessNeurilemmomaOrbital NeoplasmsOrbital PseudotumorPrednisoloneProspective StudiesPrednisoloneAdenoid Cystic CarcinomaBasal Cell CarcinomaBRAFCavernous HemangiomaCetuximabEpidermal Growth Factor ReceptorFluid-Fluid LevelsHedgehog PathwayIdiopathic Orbital InflammationMYBOptic GliomaOrbitotomyReceptor Tyrosine Kinase InhibitorSchwannomaSorafenibSquamous Cell CarcinomaTargeted TreatmentVismodegib

Identifiers

PMID26692710
PMCPMC4660525
OpenAlexW2429437960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.